Technology
Health
Biotechnology

DiaMedica Therapeutics Inc. Common Stock

272

$2.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-2.69%) As of 12:58 PM EST today
-$0.08 (-2.69%) Today

Why Robinhood?

You can buy or sell DMAC and other stocks, options, ETFs, and crypto commission-free!

About DMAC

DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS), and chronic kidney disease (CKD). Read More The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

CEO
Rick John Pauls
Employees
9
Headquarters
Minneapolis, Minnesota
Founded
2000
Market Cap
35.18K
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
38.35K
High Today
$2.94
Low Today
$2.75
Open Price
$2.80
Volume
30.16K
52 Week High
$5.93
52 Week Low
$1.70

Collections

Technology
Health
Biotechnology
Therapy
Medical
Biopharmaceutical
Pharmaceutical
2018 IPO

DMAC Earnings

-$0.27
-$0.25
-$0.22
-$0.20
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Mar 17, After Hours

You May Also Like

UAN
AGRX
BSJR
ACRE
PSF
FTSI
HYRE
QLV
GARD
USIO
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy DMAC

Market Price$2.74
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell DMAC stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up